Tradestie Institutional Equity Comparison Engine
COCP vs KZR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KZR Overall Edge
KZR Captures Institutional Edge (3โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kezar Life Sciences, Inc. Common Stock (KZR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, COCP trades at N/M Forward P/E with -3063.6% operating margin (+26.9% YoY revenue) versus KZR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, COCP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against KZR sits in UNCLASSIFIED (9th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
COCP N/M vs KZR N/M Fwd P/E
Growth & Margin Winner
KZR
Op Margin -3063.6% vs 0.0% ยท YoY +26.9% vs +0.0%
Momentum & Technical Winner
KZR
1Y -3.0% vs +78.7% ยท 52W Pos 19% vs 94%
Options & Structure Winner
KZR
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (9th %ile IV)
COCP
NASDAQ
Cocrystal Pharma, Inc. Common Stock
Pharmaceutical Preparations
$1.00
+1.98% 1D
Market Cap
$19.6M
1M Return
-2.01%
1Y Return
-2.96%
Forward P/E
N/M
Unified AI Score
47.1 / 100
HOLD
Tech 51.0
Fund 48.0
Flow 50.0
Mom 54.0
KZR
NASDAQ
Kezar Life Sciences, Inc. Common Stock
Pharmaceutical Preparations
$7.29
-0.95% 1D
Market Cap
$54.4M
1M Return
-0.82%
1Y Return
+78.68%
Forward P/E
N/M
Unified AI Score
60.1 / 100
BUY
Tech 40.0
Fund 51.0
Flow 56.0
Mom 58.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
COCP -2.96%
KZR +78.68%
Spread: +21.27 pp (COCP Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
COCP TTM Op. Margin: -3063.6%
KZR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on COCP vs KZR. Trailing 12-month operating profitability (COCP -3063.6% vs KZR 0.0%) and valuation multiples (COCP N/M vs KZR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | COCP | KZR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $19.6M | $54.4M | Larger Scale | KZR |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +26.9% | +0.0% | Higher Growth | COCP |
| Operating Margin (TTM) Profitability | -3063.6% | 0.0% | Higher Margin | KZR |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -311.7% | -59.9% | Higher ROE | KZR |
| 52-Week Range Position Momentum | 19% ($1โ$2) | 94% ($4โ$8) | Stronger Trend | KZR |
| Beta / 30D Volatility Risk Regime | 1.04ฮฒ ยท 54% Vol | 0.60ฮฒ ยท 8% Vol | Lower Realized Risk | KZR |
| Unified Institutional Score Composite Signal | 47.1 / 100 (HOLD) | 60.1 / 100 (BUY) | Higher Composite | KZR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full COCP vs KZR Buy Guide
COCP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
KZR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither COCP nor KZR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.